A simple point-of-care assay accurately detects anti-spike antibodies after SARS-CoV-2 vaccination

被引:0
|
作者
Greene, Sarah E. [1 ]
Huang, Yuefang [2 ]
Kim, Wooseob [3 ]
Liebeskind, Mariel J. [4 ]
Chandrasekaran, Vinay [4 ]
Liu, Zhuoming [5 ]
Deepak, Parakkal [6 ]
Paley, Michael A. [7 ]
Lew, Daphne [8 ]
Yang, Monica [9 ]
Matloubian, Mehrdad [9 ]
Gensler, Lianne S. [9 ,10 ]
Nakamura, Mary C. [8 ,10 ]
O'Hallaran, Jane A. [2 ]
Presti, Rachel M. [2 ]
Whelan, Sean P. J. [5 ]
Buchser, William J. [4 ]
Kim, Alfred H. J. [3 ,7 ]
Weil, Gary J. [2 ]
机构
[1] Washington Univ, Dept Pediat, Div Infect Dis, Sch Med, 4444 Forest Pk Ave,Rm 4184, St Louis, MO 63110 USA
[2] Washington Univ, Dept Med, Div Infect Dis, St Louis, MO 63130 USA
[3] Washington Univ, Dept Pathol & Immunol, Div Immunobiol, Sch Med, St Louis, MO USA
[4] Washington Univ, Dept Genet, Sch Med, St Louis, MO USA
[5] Washington Univ, Dept Mol Microbiol, Sch Med, St Louis, MO USA
[6] Washington Univ, Dept Med, Div Gastroenterol, Sch Med, St Louis, MO USA
[7] Washington Univ, Dept Med, Div Rheumatol, Sch Med, St Louis, MO USA
[8] Washington Univ, Div Biostat, Sch Med, St Louis, MO USA
[9] Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA USA
[10] San Francisco VA Hlth Care Syst, San Francisco, CA USA
来源
JOURNAL OF CLINICAL VIROLOGY PLUS | 2023年 / 3卷 / 01期
基金
美国国家卫生研究院;
关键词
SARS-COV-2; Antibody test; Vaccination; Immunocompromise;
D O I
10.1016/j.jcvp.2023.100135
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: Lateral flow assays (LFA) are sensitive for detecting antibodies to SARS-CoV-2 proteins within weeks after infection. This study tested samples from immunocompetent adults, and those receiving treatments for chronic inflammatory diseases (CID), before and after mRNA SARS-CoV-2 vaccination. Methods: We compared results obtained with the COVIBLOCK Covid-19 LFA to those obtained by anti-spike (S) ELISA. Results: The LFA detected anti-S antibodies in 29 of 29 (100%) of the immunocompetent and 110 of 126 (87.3%) of the CID participants after vaccination. Semiquantitative LFA scores were statistically significantly lower in samples from immunosuppressed participants, and were significantly correlated with anti-S antibody levels measured by ELISA. Conclusions: This simple LFA test is a practical alternative to laboratory-based assays for detecting anti-S antibodies after infection or vaccination. This type of test may be most useful for testing people in outpatient or resource-limited settings.
引用
下载
收藏
页数:5
相关论文
共 50 条
  • [41] A Biosensor Platform for Point-of-Care SARS-CoV-2 Screening
    Georgas, Antonios
    Agiannis, Konstantinos
    Papakosta, Vasiliki
    Priftis, Panagiotis
    Angelopoulos, Spyridon
    Ferraro, Angelo
    Hristoforou, Evangelos
    BIOSENSORS-BASEL, 2022, 12 (07):
  • [42] Point-of-Care SARS-CoV-2 Variant Diagnostic in Development
    Abbasi, Jennifer
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (10): : 901 - 901
  • [43] Development of Sars-Cov-2 Anti-Spike ELISA Test Inhouse- Our Experience
    Gannett, Michael
    Gammon, Richard
    Prichard, Alicia Bellido
    Benitez, Nancy
    Resto, Claribel
    Bright, Frieda
    Francis, Tara
    Smith, Judith
    Stevens, Jonah
    Thomas, Korena
    Yue, Helen
    Whitelocke, Dianne
    TRANSFUSION, 2020, 60 : 94A - 95A
  • [44] Monitoring of SARS-CoV-2 Specific Antibodies after Vaccination
    Guiomar, Raquel
    Santos, Ana Joao
    Melo, Aryse Martins
    Costa, Ines
    Matos, Rita
    Rodrigues, Ana Paula
    Kislaya, Irina
    Silva, Anabela Santos
    Roque, Carla
    Nunes, Carla
    Aguiar, Joaquim
    Graca, Fatima
    Silva Graca, Antonio
    Machado, Ausenda
    VACCINES, 2022, 10 (02)
  • [45] SARS-CoV-2 Antibodies in Breast Milk After Vaccination
    Romero Ramirez, Dolores Sabina
    Lara Perez, Maria Magdalena
    Carretero Perez, Mercedes
    Suarez Hernandez, Maria Isis
    Martin Pulido, Saul
    Pera Villacampa, Lorena
    Fernandez Vilar, Ana Maria
    Rivero Falero, Monica
    Gonzalez Carretero, Paloma
    Reyes Millan, Beatriz
    Roper, Sabine
    Garcia Bello, Miguel Angel
    PEDIATRICS, 2021, 148 (05)
  • [46] Comparison of a Roche Total Anti-spike Semiquantitative Assay Against Both a Sars-Cov-2 Plaque Reduction Neutralization Assay and a Surrogate Neutralization Assay
    Drews, Steven Jeffrey
    O'Brien, Sheila F.
    Saeed, Sahar
    Jenkins, Craig
    Conrod, Valerie
    Pambrun, Chantale
    Robinson, Alyssia
    Mendoza, Emelissa
    Manguiat, Kathy
    Wood, Heidi
    TRANSFUSION, 2021, 61 : 39A - 39A
  • [47] Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2
    Chen, Jonathan Hon-Kwan
    Yip, Cyril Chik-Yan
    Poon, Rosana Wing-Shan
    Chan, Kwok-Hung
    Cheng, Vincent Chi-Chung
    Hung, Ivan Fan-Ngai
    Chan, Jasper Fuk-Woo
    Yuen, Kwok-Yung
    To, Kelvin Kai-Wang
    EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 1356 - 1359
  • [48] Rapid Point-of-Care Assay by SERS Detection of SARS-CoV-2 Virus and Its Variants
    Guan, Peng-Cheng
    Zhang, Hong
    Li, Zhi-Yong
    Xu, Shan-Shan
    Sun, Miao
    Tian, Xian-Min
    Lin, Jia-Sheng
    Wen, Huan
    Zhang, Fan-Li
    Zhang, Yue-Jiao
    Ma, Zhan
    Yu, Guang-Jun
    Yang, Chaoyong
    Wang, Zhan-Xiang
    Song, Yanling
    Li, Jian-Feng
    Gu, Man-Man
    ANALYTICAL CHEMISTRY, 2022, 94 (51) : 17795 - 17802
  • [49] Anti-spike protein antibody titer at the time of breakthrough infection of SARS-CoV-2 omicron
    Adachi, Eisuke
    Nagai, Etsuko
    Saito, Makoto
    Isobe, Masamichi
    Konuma, Takaaki
    Koga, Michiko
    Tsutsumi, Takeya
    Nannya, Yasuhito
    Yotsuyanagi, Hiroshi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (07) : 1015 - 1017
  • [50] Rapid Determination of SARS-CoV-2 antibodies using a bedside, point-of-Care, serological test
    Dortet, Laurent
    Emeraud, Cecile
    Vauloup-Fellous, Christelle
    Khecharem, Mouna
    Ronat, Jean-Baptiste
    Fortineau, Nicolas
    Roque-Afonso, Anne-Marie
    Naas, Thierry
    EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 2212 - 2221